查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1701350

RNA靶向小分子药物发现市场规模、份额、趋势分析报告：按适应症、最终用途、地区、分部预测、分部预测，2025-2030年

RNA Targeting Small Molecule Drug Discovery Market Size, Share & Trends Analysis Report By Indication (Cancer, Infectious Diseases, Metabolic Diseases, Neurological Diseases), By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

RNA靶向小分子药物研发市场的成长与趋势：

根据Grand View Research, Inc.的最新报告，全球RNA标靶小分子药物研发市场规模预计到2030年将达到54.2亿美元，2025年至2030年的复合年增长率为21.9%。

RNA 标靶小分子药物研发产业因其有可能为多种疾病开发有效的标靶化治疗方法而持续快速成长。

癌症、遗传性疾病和病毒感染等疾病的日益流行，推动了对 RNA 靶向小分子药物的需求。随着 CRISPR-Cas9 和RNA干扰等最尖端科技的引入，RNA 标靶小分子药物研发产业得到了显着发展。这些技术使得识别与疾病发作有关的 RNA 标靶成为可能，并促进了针对 RNA 的全新小分子药物的开发。

未来几年，受製药和生物技术公司研发活动支出增加的推动，用于药物研发的 RNA 靶向小分子市场预计将大幅扩张。产生创新 RNA 标靶小分子的过程既费时又昂贵，但集中、高效治疗带来的潜在回报使其值得投资。

例如，Moderna于2020年与Vertex Pharmaceuticals合作开发用于治疗囊肿纤维化的RNA标靶小分子药物，就是对该领域的重大投资。 Moderna 将利用其 mRNA 技术平台来识别新的 RNA 靶点，而 Vertex 将运用其小分子药物发现专业知识来开发针对这些标靶的治疗方法。此次合作反映出人们对 RNA 标靶小分子药物研发的兴趣和投资日益增长，这有可能彻底改变疾病治疗。

RNA标靶小分子药物研发市场报告重点

  • 根据适应症，肿瘤学在预测期内将呈现最高的复合年增长率，为 22.3%。该领域的高成长很大程度上是由于癌症盛行率的不断上升以及对更有效治疗方法的迫切需求。
  • 在 RNA 靶向小分子药物研发产业，製药和生物製药公司占据最终用户领域的主导地位，2024 年的市场占有率为 59.4%。这是由于该领域对研发活动的大量投资以及将新药推向市场的专业知识。
  • 预计到 2024 年，北美将占据全球市场的最大收入份额，达到 60.7%，这得益于主要市场参与者的存在、先进的医疗保健基础设施以及研发活动投资的增加等因素。该地区拥有完善的医疗保健体系，支持新治疗方法的开发和商业化，这为其在该市场占据优势做出了贡献。

目录

第一章调查方法与范围

第二章执行摘要

第三章 RNA 标靶小分子药物研发市场变数、趋势与范围

  • 市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 商业环境分析
    • 产业分析-波特五力分析
    • PESTLE分析

第四章 RNA 标靶小分子药物研发市场：按适应症进行的业务分析

  • 2024年及2030年指示市场占有率
  • 指示细分仪表板
  • 市场规模、预测与趋势分析（2018-2030 年）
  • 癌症
  • 感染疾病
  • 代谢紊乱
  • 神经系统疾病
  • 其他的

第五章 RNA 标靶小分子药物研发市场：依最终用途进行的业务分析

  • 2024 年及 2030 年最终用途市场占有率
  • 最终用途细分仪表板
  • 按最终用途分類的市场规模、预测和趋势分析（2018-2030 年）
  • 製药和生物製药公司
  • 学术研究所
  • 其他的

第六章 RNA 标靶小分子药物研发市场：区域估计与趋势分析

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 市场规模、预测趋势分析，2018 年至 2030 年：
  • 北美洲
    • 2018-2030年各国情况
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 2018-2030年各国情况
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 丹麦
    • 瑞典
  • 亚太地区
    • 2018-2030年各国情况
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 2018-2030年各国情况
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 2018-2030年各国情况
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章竞争格局

  • 参与者概述
  • 企业市场分析
  • 公司分类
  • 战略地图
  • 公司简介/列表
    • ACCENT THERAPEUTICS
    • Anima Biotech Inc.
    • Arrakis Therapeutics
    • AstraZeneca
    • Epics Therapeutics
    • Expansion Therapeutics
    • F. Hoffmann-La Roche Ltd
    • PTC Therapeutics, Inc.
    • Ribometrix
    • LES LABORATOIRES SERVIER
    • Skyhawk Therapeutics
Product Code: GVR-4-68040-049-3

RNA Targeting Small Molecule Drug Discovery Market Growth & Trends:

The global RNA targeting small molecule drug discovery market size is estimated to reach USD 5.42 billion by 2030, registering a CAGR of 21.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. RNA-targeting small molecule drug discovery industry continues to undergo rapid growth due to its potential to develop targeted and effective therapeutics for various diseases.

The increasing prevalence of diseases such as cancer, genetic disorders, and viral infections has fueled the demand for RNA-targeting small-molecule drugs. The RNA-targeting small molecule drug discovery industry has grown dramatically as a result of the introduction of cutting-edge technologies like CRISPR-Cas9 and RNA interference. These technologies have made it possible to identify RNA targets that are implicated in the pathogenesis of diseases, which has resulted in the creation of brand-new small-molecule medications that target RNA.

In the upcoming years, the market for RNA targeting small molecules for drug discovery is anticipated to experience significant expansion, driven by the rising expenditure in R&D activities by pharmaceutical and biotechnology businesses. The process of creating innovative, RNA-targeting small molecules is time-consuming and costly, but the potential rewards of focused, efficient treatments make it a worthy investment.

For instance, in 2020 Moderna's recent collaboration with Vertex Pharmaceuticals to develop RNA-targeted small molecule drugs for the treatment of cystic fibrosis is a significant investment in this field. Moderna will use its mRNA technology platform to identify novel RNA targets, while Vertex will apply its expertise in small molecule drug discovery to develop therapies for the targets. This collaboration reflects the growing interest and investment in RNA-targeting small molecule drug discovery, which has the potential to revolutionize disease treatment.

RNA Targeting Small Molecule Drug Discovery Market Report Highlights:

  • Cancer in the indication segment witnessed the highest CAGR of 22.3% ovre the forecast period. The high growth of the segment is majorly due to the increasing prevalence of cancer and the urgent need for more effective treatments.
  • Pharmaceutical and biopharmaceutical companies dominated the RNA-targeting small molecule drug discovery industry in the end-user segment, with a market share of 59.4% in 2024. This is due to their significant investment in research and development activities in this field, as well as their expertise in bringing new drugs to market.
  • North America held the maximum revenue share of 60.7% of the global market in 2024, due to factors such as the presence of key market players, advanced healthcare infrastructure, and increasing investment in research and development activities. This region has a well-established healthcare system that supports the development and commercialization of new therapies, which contributes to its dominance in the market.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Indication
    • 1.2.2. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. RNA Targeting Small Molecule Drug Discovery Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. RNA Targeting Small Molecule Drug Discovery Market: Indication Business Analysis

  • 4.1. Indication Market Share, 2024 & 2030
  • 4.2. Indication Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Indication, 2018 to 2030 (USD Million)
  • 4.4. Cancer
    • 4.4.1. Cancer Market, 2018 - 2030 (USD Million)
  • 4.5. Infectious Diseases
    • 4.5.1. Infectious Diseases Market, 2018 - 2030 (USD Million)
  • 4.6. Metabolic Diseases
    • 4.6.1. Metabolic Diseases Market, 2018 - 2030 (USD Million)
  • 4.7. Neurological Diseases
    • 4.7.1. Neurological Diseases Market, 2018 - 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. RNA Targeting Small Molecule Drug Discovery Market: End Use Business Analysis

  • 5.1. End Use Market Share, 2024 & 2030
  • 5.2. End Use Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 5.4. Pharmaceutical and Biopharmaceutical Companies
    • 5.4.1. Pharmaceutical and Biopharmaceutical Companies Market, 2018 - 2030 (USD Million)
  • 5.5. Academic and Research Institutes
    • 5.5.1. Academic and Research Institutes Market, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. RNA Targeting Small Molecule Drug Discovery Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.4. North America
    • 6.4.1. North America RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Regulatory Framework
      • 6.4.2.3. Competitive Insights
      • 6.4.2.4. U.S. RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Regulatory Framework
      • 6.4.3.3. Competitive Insights
      • 6.4.3.4. Canada RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Regulatory Framework
      • 6.4.4.3. Competitive Insights
      • 6.4.4.4. Mexico RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Regulatory Framework
      • 6.5.2.3. Competitive Insights
      • 6.5.2.4. UK RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Regulatory Framework
      • 6.5.3.3. Competitive Insights
      • 6.5.3.4. Germany RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Regulatory Framework
      • 6.5.4.3. Competitive Insights
      • 6.5.4.4. France RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Regulatory Framework
      • 6.5.5.3. Competitive Insights
      • 6.5.5.4. Italy RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Regulatory Framework
      • 6.5.6.3. Competitive Insights
      • 6.5.6.4. Spain RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Norway
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Regulatory Framework
      • 6.5.7.3. Competitive Insights
      • 6.5.7.4. Norway RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.8. Denmark
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Regulatory Framework
      • 6.5.8.3. Competitive Insights
      • 6.5.8.4. Denmark RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.9. Sweden
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Regulatory Framework
      • 6.5.9.3. Competitive Insights
      • 6.5.9.4. Sweden RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Regulatory Framework
      • 6.6.2.3. Competitive Insights
      • 6.6.2.4. Japan RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Regulatory Framework
      • 6.6.3.3. Competitive Insights
      • 6.6.3.4. China RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Regulatory Framework
      • 6.6.4.3. Competitive Insights
      • 6.6.4.4. India RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Regulatory Framework
      • 6.6.5.3. Competitive Insights
      • 6.6.5.4. South Korea RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.6. Australia
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Regulatory Framework
      • 6.6.6.3. Competitive Insights
      • 6.6.6.4. Australia RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Regulatory Framework
      • 6.6.7.3. Competitive Insights
      • 6.6.7.4. Thailand RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Regulatory Framework
      • 6.7.2.3. Competitive Insights
      • 6.7.2.4. Brazil RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Regulatory Framework
      • 6.7.3.3. Competitive Insights
      • 6.7.3.4. Argentina RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.8. MEA
    • 6.8.1. MEA RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Regulatory Framework
      • 6.8.2.3. Competitive Insights
      • 6.8.2.4. South Africa RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Regulatory Framework
      • 6.8.3.3. Competitive Insights
      • 6.8.3.4. Saudi Arabia RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Regulatory Framework
      • 6.8.4.3. Competitive Insights
      • 6.8.4.4. UAE RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Regulatory Framework
      • 6.8.5.3. Competitive Insights
      • 6.8.5.4. Kuwait RNA Targeting Small Molecule Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. ACCENT THERAPEUTICS
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Product Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. Anima Biotech Inc.
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Product Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. Arrakis Therapeutics
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Product Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. AstraZeneca
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. Epics Therapeutics
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Product Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. Expansion Therapeutics
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. F. Hoffmann-La Roche Ltd
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. PTC Therapeutics, Inc.
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic Initiatives
    • 7.5.9. Ribometrix
      • 7.5.9.1. Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Product Benchmarking
      • 7.5.9.4. Strategic Initiatives
    • 7.5.10. LES LABORATOIRES SERVIER
      • 7.5.10.1. Overview
      • 7.5.10.2. Financial Performance
      • 7.5.10.3. Product Benchmarking
      • 7.5.10.4. Strategic Initiatives
    • 7.5.11. Skyhawk Therapeutics
      • 7.5.11.1. Overview
      • 7.5.11.2. Financial Performance
      • 7.5.11.3. Product Benchmarking
      • 7.5.11.4. Strategic Initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global RNA targeting small molecule drug discovery market, by region, 2018 - 2030 (USD Million)
  • Table 4. Global RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 5. Global RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 6. North America RNA targeting small molecule drug discovery market, by country, 2018 - 2030 (USD Million)
  • Table 7. North America RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 8. North America RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 9. U.S. RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 10. U.S. RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 11. Canada RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 12. Canada RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 13. Mexico RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 14. Mexico RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 15. Europe RNA targeting small molecule drug discovery market, by country, 2018 - 2030 (USD Million)
  • Table 16. Europe RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 17. Europe RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 18. UK RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 19. UK RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 20. Germany RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 21. Germany RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 22. France RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 23. France RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 24. Italy RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 25. Italy RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 26. Spain RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 27. Spain RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 28. Norway RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 29. Norway RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 30. Denmark RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 31. Denmark RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 32. Sweden RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 33. Sweden RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 34. Asia Pacific RNA targeting small molecule drug discovery market, by country, 2018 - 2030 (USD Million)
  • Table 35. Asia Pacific RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 36. Asia Pacific RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 37. Japan RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 38. Japan RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 39. China RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 40. China RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 41. India RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 42. India RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 43. Australia RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 44. Australia RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 45. South Korea RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 46. South Korea RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 47. Thailand RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 48. Thailand RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 49. Latin America RNA targeting small molecule drug discovery market, by country, 2018 - 2030 (USD Million)
  • Table 50. Latin America RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 51. Latin America RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 52. Brazil RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 53. Brazil RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 54. Argentina RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 55. Argentina RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 56. Middle East & Africa RNA targeting small molecule drug discovery market, by country, 2018 - 2030 (USD Million)
  • Table 57. Middle East & Africa RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 58. Middle East & Africa RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 59. South Africa RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 60. South Africa RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 61. Saudi Arabia RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 62. Saudi Arabia RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 63. UAE RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 64. UAE RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)
  • Table 65. Kuwait RNA targeting small molecule drug discovery market, by indication, 2018 - 2030 (USD Million)
  • Table 66. Kuwait RNA targeting small molecule drug discovery market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 RNA targeting small molecule drug discovery market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Indication and end use outlook (USD Million)
  • Fig. 10 Competitive landscape
  • Fig. 11 RNA targeting small molecule drug discovery market dynamics
  • Fig. 12 RNA targeting small molecule drug discovery market: Porter's five forces analysis
  • Fig. 13 RNA targeting small molecule drug discovery market: PESTLE analysis
  • Fig. 14 RNA targeting small molecule drug discovery market: Indication segment dashboard
  • Fig. 15 RNA targeting small molecule drug discovery market: Indication market share analysis, 2024 & 2030
  • Fig. 16 Cancer market, 2018 - 2030 (USD Million)
  • Fig. 17 Infectious diseases market, 2018 - 2030 (USD Million)
  • Fig. 18 Metabolic diseases market, 2018 - 2030 (USD Million)
  • Fig. 19 Neurological diseases market, 2018 - 2030 (USD Million)
  • Fig. 20 Others market, 2018 - 2030 (USD Million)
  • Fig. 21 RNA targeting small molecule drug discovery market: End use segment dashboard
  • Fig. 22 RNA targeting small molecule drug discovery market: End use market share analysis, 2024 & 2030
  • Fig. 23 Pharmaceutical and biopharmaceutical companies market, 2018 - 2030 (USD Million)
  • Fig. 24 Academic and research institutes market, 2018 - 2030 (USD Million)
  • Fig. 25 Others market, 2018 - 2030 (USD Million)
  • Fig. 26 RNA targeting small molecule drug discovery market revenue, by region
  • Fig. 27 Regional marketplace: Key takeaways
  • Fig. 28 Regional marketplace: Key takeaways
  • Fig. 29 North America RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 30 U.S. country dynamics
  • Fig. 31 U.S. RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 32 Canada country dynamics
  • Fig. 33 Canada RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 34 Mexico country dynamics
  • Fig. 35 Mexico RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 36 Europe RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 37 UK country dynamics
  • Fig. 38 UK RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 39 Germany country dynamics
  • Fig. 40 Germany RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 41 France country dynamics
  • Fig. 42 France RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 43 Italy country dynamics
  • Fig. 44 Italy RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 45 Spain country dynamics
  • Fig. 46 Spain RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 47 Norway country dynamics
  • Fig. 48 Norway RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 49 Sweden country dynamics
  • Fig. 50 Sweden RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 51 Denmark country dynamics
  • Fig. 52 Denmark RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 53 Asia Pacific RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 54 Japan country dynamics
  • Fig. 55 Japan RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 56 China country dynamics
  • Fig. 57 China RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 58 India country dynamics
  • Fig. 59 India RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 60 Australia country dynamics
  • Fig. 61 Australia RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 62 South Korea country dynamics
  • Fig. 63 South Korea RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 64 Thailand country dynamics
  • Fig. 65 Thailand RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 66 Latin America RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 67 Brazil country dynamics
  • Fig. 68 Brazil RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 69 Argentina country dynamics
  • Fig. 70 Argentina RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 71 MEA RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 72 South Africa country dynamics
  • Fig. 73 South Africa RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 74 Saudi Arabia country dynamics
  • Fig. 75 Saudi Arabia RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 76 UAE country dynamics
  • Fig. 77 UAE RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 78 Kuwait country dynamics
  • Fig. 79 Kuwait RNA targeting small molecule drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 80 Company categorization
  • Fig. 81 Company market position analysis
  • Fig. 82 Strategic framework